Search

everythinglearnresearchcommunity

for

Search:↓

AGA patients have fewer hairs and smaller follicles; T:V ratio above 4:1 may indicate AGA.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Liposomes improve the delivery and effectiveness of cosmetic ingredients but face challenges like cost and stability.

Women with PCOS had higher SRAGE levels, possibly linked to BMI, not PCOS.

Combining hyaluronic acid and oxygen may help improve urinary incontinence in menopausal women.

Liposomes could improve how skin care products work but are costly and not very stable.

Ascorbic acid derivatives improve drug delivery systems.

Menopause affects skin and hair, and more research is needed for effective treatments.

Radiotherapy can cause skin fibrosis, which is often overlooked and needs better treatment and evaluation.

Quadruple-coated probiotics significantly improve IBS symptoms.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Pregnancy can cause skin darkening, varicose veins, more sweating, hair growth, hair loss after birth, nail changes, and gum inflammation.

Hormones, especially androgens, play a big role in acne, but most acne sufferers don't have a hormone disorder. Hormonal treatments, including birth control pills, can be very effective for women whose acne doesn't improve with regular treatments.

Pregnancy can cause skin pigmentation, stretch marks, and changes in hair, nails, and sweat glands, with most resolving after birth.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Electrospun nanofibers show promise for enhancing blood vessel growth in tissue engineering but need further research to improve their effectiveness.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

The document concludes that more research is needed to understand how to treat muscle pain with drugs.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.